Clinical Trial

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 17, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aimed to compare the efficacy and safety of a precision treatment regimen based on clinical-molecular phenotypes with a conventional treatment regimen in the treatment of patients with active Takayasu's arteritis based on a randomized, controlled, open-label, multicenter study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-10.
Trial Details
NCT Number NCT06498089
Lead Sponsor Shanghai Zhongshan Hospital
Conditions Takayasu Arteritis
Enrollment 124 participants
Start Date 2024-06-28
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-17